Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Heico
HEI
CA Stock MarketDetailed Quotes
GWS Xtacy Therapeutics Corp
- 0.045
- 0.0000.00%
15min DelayTrading Sep 25 16:00 ET
2.21MMarket Cap-2.25P/E (TTM)
0.000High0.000Low0Volume0.000Open0.045Pre Close0.00Turnover0.05052wk High0.00%Turnover Ratio49.21MShares0.04552wk Low-0.02EPS TTM1.95MFloat Cap67.500Historical HighLossP/E (Static)43.32MShs Float0.038Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM-3.75P/B1Lot Size--Div YieldTTM
About Xtacy Therapeutics Corp Company
No Data
Company Profile
SymbolGWS
Company NameXtacy Therapeutics Corp
Company Executives
- Name
- Position
- Salary
- Meris Kott
- Chief Executive Officer and Director
- --
- Stephen Brohman
- Chief Financial Officer
- --
- Mark Ireton
- Director
- --
- Lindsey Perry Jr.
- Director
- --
- Ashleigh Vogstad
- Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting